|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic Science Investigation |
1 Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan; 2 Cancer Center and Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan; 3 Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan; 4 Experimental Diagnostic Imaging, M.D. Anderson Cancer Center, Houston, Texas; 5 Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan; 6 Department of Diagnostic Radiology, Taipei Medical University Hospital, Taipei, Taiwan; 7 Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan; 8 Division of General Surgery, Department of Surgery and Cancer Center, Taipei Medical University Hospital, Taipei, Taiwan; 9 Department of Food and Nutrition, Providence University, Taichung, Taiwan; 10 Department of Prosthetic Dentistry, School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan; and 11 Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, Taipei, Taiwan
Correspondence: For correspondence or reprints contact: Win-Ping Deng, Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, 250 Wu-Hsing St., Taipei, 110, Taiwan. E-mail: wpdeng{at}tmu.edu.tw
The aim of this study was to develop a cell-based bone-regeneration approach evaluated by molecular imaging and immunohistochemistry. Methods: Genetically modified NIH3T3 embryonic fibroblasts carrying enhanced green fluorescent protein (NIH3T3-G) were predifferentiated into osteoblastlike cells using platelet-rich plasma (PRP) medium, followed by intraosseous transplantation into ovariectomized senescence-accelerated mouse prone substrain 8 (OVX-SAMP8 mice). Results: PRP-conditioned NIH3T3-G (PRP/NIH3T3-G) engraftment prevented the development of osteoporosis. Molecular imaging and immunohistochemistry demonstrated the migration of NIH3T3-G cells from the implantation site throughout the skeleton. In situ analyses revealed coexpression of osteopontin and green fluorescent protein in the newly formed bone tissue, demonstrating that the transplant restored the bone trabecular architecture and mineral density in treated OVX-SAMP8 mice. Interestingly, the life span of OVX-SAMP8 mice receiving PRP/NIH3T3-G transplantation was significantly prolonged and similar to that of the congenic senescence-resistant strain of mice. Conclusion: This unique and yet simple approach could potentially be applied to the treatment of senile postmenopausal osteoporosis and perhaps inborn genetic syndromes associated with accelerated aging, such as Hutchinson–Gilford progeria syndrome, and for the prolongation of life expectancy in general.
Key Words: bone molecular biology molecular imaging osteogenesis platelet-rich plasma transplantation senescence-accelerated mice P8
COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |